Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias von Cortes, Jorge E, Kantarjian, Hagop, Shah, Neil P, Bixby, Dale, Mauro, Michael J, Flinn, Ian, O'Hare, Thomas, Hu, Simin, Narasimhan, Narayana I, Rivera, Victor M, Clackson, Tim, Turner, Christopher D, Haluska, Frank G, Druker, Brian J, Deininger, Michael W.N, Talpaz, Moshe

Volltext

Alu elements: know the SINEs von Deininger, Prescott

Volltext

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure von Hughes, Timothy P, Mauro, Michael J, Cortes, Jorge E, Minami, Hironobu, Rea, Delphine, DeAngelo, Daniel J, Breccia, Massimo, Goh, Yeow-Tee, Talpaz, Moshe, Hochhaus, Andreas, le Coutre, Philipp, Ottmann, Oliver, Heinrich, Michael C, Steegmann, Juan L, Deininger, Michael W.N, Janssen, Jeroen J.W.M, Mahon, Francois-Xavier, Minami, Yosuke, Yeung, David, Ross, David M, Tallman, Martin S, Park, Jae H, Druker, Brian J, Hynds, David, Duan, Yuyan, Meille, Christophe, Hourcade-Potelleret, Florence, Vanasse, K. Gary, Lang, Fabian, Kim, Dong-Wook

Volltext

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial von Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop

Volltext

Turning the tide in myelodysplastic/myeloproliferative neoplasms von Deininger, Michael W. N., Tyner, Jeffrey W., Solary, Eric

Volltext

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants von O'HARE, Thomas, WALTERS, Denise K, DRUKER, Brian J, STOFFREGEN, Eric P, TAIPING JIA, MANLEY, Paul W, MESTAN, Jürgen, COWAN-JACOB, Sandra W, LEE, Francis Y, HEINRICH, Michael C, DEININGER, Michael W. N

Volltext

Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia von O'Hare, Thomas, Eide, Christopher A., Deininger, Michael W.N.

Volltext

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial von Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael W, Mauro, Michael J, Chuah, Charles, Kim, Dong-Wook, Dyagil, Irina, Glushko, Nataliia, Milojkovic, Dragana, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Reilly, Laurence, Jeynes-Ellis, Allison, Leip, Eric, Bardy-Bouxin, Nathalie, Hochhaus, Andreas, Brümmendorf, Tim H

Volltext

Quantifying Spillover Effects from Large Land-based Investment: The Case of Mozambique von Deininger, Klaus, Xia, Fang

Volltext

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia von Soverini, Simona, Branford, Susan, Nicolini, Franck E, Talpaz, Moshe, Deininger, Michael W.N, Martinelli, Giovanni, Müller, Martin C, Radich, Jerald P, Shah, Neil P

Volltext

Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment von VanderVen, Brian C, Fahey, Ruth J, Lee, Wonsik, Liu, Yancheng, Abramovitch, Robert B, Memmott, Christine, Crowe, Adam M, Eltis, Lindsay D, Perola, Emanuele, Deininger, David D, Wang, Tiansheng, Locher, Christopher P, Russell, David G

Volltext

The Rise of Large Farms in Land Abundant Countries: Do They Have a Future? von Deininger, Klaus, Byerlee, Derek

Volltext

Land rental markets in the process of rural structural transformation: Productivity and equity impacts from China von Jin, Songqing, Deininger, Klaus

Volltext

Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia von O'HARE, Thomas, DEININGER, Michael W. N, EIDE, Christopher A, CLACKSON, Tim, DRUKER, Brian J

Volltext

Environmental and gender impacts of land tenure regularization in Africa: Pilot evidence from Rwanda von Ali, Daniel Ayalew, Deininger, Klaus, Goldstein, Markus

Volltext

Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia von Moslehi, Javid J, Deininger, Michael

Volltext

Robust subtyping of non‐small cell lung cancer whole sections through MALDI mass spectrometry imaging von Janßen, Charlotte, Boskamp, Tobias, Hauberg‐Lotte, Lena, Behrmann, Jens, Deininger, Sören‐Oliver, Kriegsmann, Mark, Kriegsmann, Katharina, Steinbuß, Georg, Winter, Hauke, Muley, Thomas, Casadonte, Rita, Kriegsmann, Jörg, Maaß, Peter

Volltext

Normalization in MALDI-TOF imaging datasets of proteins: practical considerations von Deininger, Sören-Oliver, Cornett, Dale S., Paape, Rainer, Becker, Michael, Pineau, Charles, Rauser, Sandra, Walch, Axel, Wolski, Eryk

Volltext

Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues von Casadonte, Rita, Kriegsmann, Mark, Zweynert, Friederike, Friedrich, Katrin, Bretton, Gustavo, Otto, Mike, Deininger, Sören-Oliver, Paape, Rainer, Belau, Eckhard, Suckau, Detlev, Aust, Daniela, Pilarsky, Christian, Kriegsmann, Jörg

Volltext

Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human mal... von SCHITTENHELM, Marcus M, SHIRAGA, Sharon, SCHROEDER, Arin, CORBIN, Amie S, GRIFFITH, Diana, LEE, Francis Y, BOKEMEYER, Carsten, DEININGER, Michael W. N, DRUKER, Brian J, HEINRICH, Michael C

Volltext